RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) announced today that the Company has received its FDA consulting firm’s analysis and requirements for the preparation of an FDA medical device submission.
RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) announced today that the Company has received its FDA consulting firm’s analysis and requirements for the preparation of an FDA medical device submission.
